BPC-157 and MK-2866 Interaction

Compatible
Researched 90% confidence

BPC-157 and MK-2866 have a compatible interaction with 90% confidence. No known negative interactions. BPC-157 supports tendon and connective tissue healing through distinct mechanisms unrelated to androgen receptor signaling. Can be used concurrently to support joint and soft tissue health during training. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

MK-2866

Selective Androgen Receptor Modulator | Muscle Wasting Research

MK-2866 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a partial agonist in muscle and bone tissue. Upon binding, the MK-2866-AR complex undergoes a conformational change that promotes nuclear translocation and interaction with androgen response elements (AREs) on DNA, activating transcription of genes involved in protein synthesis, nitrogen retention, and myogenic differentiation.

Half-life: ~24 hours Typical dose: 10-25 mg/day oral sarm, anabolic
androgen receptormtormyostatin androgeniccarcinogenic riskhepatotoxichpta suppressive
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (BPC-157, MK-2866). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with MK-2866?

Yes, BPC-157 and MK-2866 can generally be taken together. No known negative interactions. BPC-157 supports tendon and connective tissue healing through distinct mechanisms unrelated to androgen receptor signaling. Can be used concurrently to support joint and soft tissue health during training.

Is BPC-157 and MK-2866 safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: carcinogenic risk. Monitor accordingly.

What are the interactions between BPC-157 and MK-2866?

No known negative interactions. BPC-157 supports tendon and connective tissue healing through distinct mechanisms unrelated to androgen receptor signaling. Can be used concurrently to support joint and soft tissue health during training. This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and MK-2866?

BPC-157 has a half-life of <30 minutes and MK-2866 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs MK-2866

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.